You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RANKL

Showing 1 - 25 of 295
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Charcot Joint of Foot Trial in Chandigarh (Danosumab)

Active, not recruiting
  • Charcot Joint of Foot
  • Chandigarh, India
    Deptt of Endocrinology
Mar 21, 2023

Periodontitis, Smoking Trial in Yeni?mahalle (GCF and saliva analysis)

Completed
  • Periodontitis
  • Smoking
  • GCF and saliva analysis
  • Yeni̇mahalle, Ankara, Turkey
    Ece Güner
Oct 24, 2023

PraG With RANKL Inhibitor for Treatment of Advanced Multiple

Not yet recruiting
  • Metastatic Solid Tumor
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Aug 16, 2022

Periodontitis Trial in Rize (biochemical analysis)

Completed
  • Periodontitis
  • biochemical analysis
  • Rize, Turkey
    Recep Tayyip Erdogan University
Oct 18, 2023

Periapical Diseases Trial in Van (Er,Cr:YSSG laser, Control)

Active, not recruiting
  • Periapical Diseases
  • Er,Cr:YSSG laser
  • Control
  • Van, Turkey
    Yuzuncu Yıl University
Jul 28, 2022

Peri-Implantitis Trial in Van (Er, Cr: YSGG laser-assisted non-surgical mechanical therapy, Non-surgical mechanical therapy)

Completed
  • Peri-Implantitis
  • Er, Cr: YSGG laser-assisted non-surgical mechanical therapy
  • Non-surgical mechanical therapy
  • Van, Turkey
    Nazli Zeynep Alpaslan
Sep 13, 2023

IL-17, TNF-alpha, RANKL Levels in Gingival Cervicular Fluid

Not yet recruiting
  • Apical Periodontitis
  • The teeth diagnosed with chronic apical periodontitis
  • (no location specified)
Feb 1, 2022

Periodontal Diseases Trial in Konya (ELISA)

Completed
  • Periodontal Diseases
  • ELISA
  • Konya, Turkey
    Necmettin Erbakan University
May 7, 2023

Type II Diabetes Trial in Corbeil-Essonnes (pratice physical activity)

Recruiting
  • Type II Diabetes
  • pratice physical activity
  • Corbeil-Essonnes, France
    Centre Hospitalier Sud Francilien
May 10, 2022

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

Healthy Trial in Haikou (HS-20090, Xgeva®)

Not yet recruiting
  • Healthy
  • Haikou, Hainan, China
    Haikou People's Hospital
Mar 8, 2023

Osteoporosis, Postmenopausal Trial in Beijing (MW031, Placebo)

Completed
  • Osteoporosis, Postmenopausal
  • Beijing, Beijing, China
    Peking Union Hospital
Jan 18, 2022

Orthodontic Tooth Movement, Gingival Crevicular Fluid, Biomarkers Trial in Madrid (Vibrational forces, Orthodontic treatment

Completed
  • Orthodontic Tooth Movement
  • +2 more
  • Vibrational forces
  • Orthodontic treatment with clear aligners
  • Madrid, Spain
    Faculty of Odontology, University Complutense Madrid
Mar 30, 2022

Prognostic Prediction Based on Radiomics of Giant Cell Tumor of

Completed
  • Spinal Tumor
  • RANK/RANKL(RANK: Receptor Activator of Nuclear factor Kappa-Β /RANKL:Receptor Activator of Nuclear factor Kappa-Β Ligand)
  • Beijing, Please Select An Option Below, China
    Peking University third hospital
Jun 28, 2021

Denosumab on Vascular and Bone Metabolism in Osteoporotic

Not yet recruiting
  • Osteoporosis
  • Chronic Kidney Disease 5D
  • MDCT (multidetector computed tomography)
  • Dual-energy X-ray absorptiometry
  • (no location specified)
Apr 13, 2022

Postmenopausal Trial in Xuzhou (HLX14, Prolia®)

Recruiting
  • Postmenopausal
  • HLX14
  • Prolia®
  • Xuzhou, Jiangsu, China
    Affiliated Hospital of Xuzhou Medical University
Jul 8, 2022

Bone Metastases Trial in Beijing (MW032, Xgeva)

Active, not recruiting
  • Bone Metastases
  • Beijing, Beijing, China
    Fifth Medical Center of PLA General Hospital
Aug 31, 2021

Osteoporosis, Hypercholesterolemia Trial (Atorvastatin)

Completed
Has Results
  • Osteoporosis
  • Hypercholesterolemia
  • (no location specified)
Apr 30, 2021

Bone Metastases From Solid Tumors Trial in Guangzhou (LY01011, Xgeva®)

Recruiting
  • Bone Metastases From Solid Tumors
  • Guangzhou, China
    The First Affiliated Hospital of Guangdong Pharmaceutical Univer
Jun 2, 2021

Hand Osteoarthritis Trial in Gent (denosumab, Placebo, Calcium/Vit D supplementation)

Completed
  • Hand Osteoarthritis
  • Gent, Belgium
    UZ Ghent
May 25, 2021

Biological Markers Trial (Double Antibiotic paste, Calcium Hydroxide Paste - Non-Setting)

Unknown status
  • Biological Markers
  • Double Antibiotic paste
  • Calcium Hydroxide Paste - Non-Setting
  • (no location specified)
Oct 13, 2020

Postmenopausal Osteoporosis Trial in Shanghai (LY06006)

Recruiting
  • Postmenopausal Osteoporosis
  • Shanghai, Shanghai, China
    Shanghai Sixth People's Hospital
Sep 17, 2021

Calcific Aortic Stenosis Trial in Edinburgh (Denosumab, Alendronic Acid, Denosumab Placebo)

Completed
  • Calcific Aortic Stenosis
  • Edinburgh, United Kingdom
    Clinical Research Facility University of Edinburgh
Oct 13, 2021

Edentulous Jaw, Bone Loss, Alveolar, Resorption, Bone Trial in Hatay (Application of concentrated growth factor with dental

Completed
  • Edentulous Jaw
  • +2 more
  • Application of concentrated growth factor with dental implants
  • +3 more
  • Hatay, Turkey
    Mustafa Kemal University
Apr 14, 2021

Circulating Myokine Levels and Bone Metabolism

Completed
  • Osteoporosis, Postmenopausal
  • Thessaloniki, Northern Greece, Greece
    424 General Military Hospital
Jan 11, 2021